LVenture

Luigi Capello serves as both CEO and investment committee member, making him the central decision-maker for capital allocation and portfolio construction. The investment team operates from the Rome office within the LUISS EnLabs campus, evaluating approximately 500 startups annually to arrive at 10–15 new positions. Capello's dual role across fund management and the accelerator means deal sourcing and underwriting are integrated under a single executive structure, rather than a distributed partnership model typical of larger VC firms.

The firm's primary sourcing channel is the LUISS EnLabs accelerator, a proprietary program run in partnership with LUISS Guido Carli University. Startups accepted into the 4- to 6-month residency receive workspace, mentorship, and a convertible grant in exchange for equity. This model generates a pipeline of vetted, post-program companies that LVenture can fund at the pre-seed and seed stages. The firm also sources from Italy's university ecosystem and co-investor networks including CDP Venture Capital.

LVenture Group S.p.A. is a publicly traded venture capital firm listed on Euronext Milan's AIM Italia segment. It operates as an operating company that makes direct equity investments from its balance sheet, rather than managing limited-partner funds with finite lives. This permanent-capital structure eliminates fund-cycle pressure and allows the firm to hold positions indefinitely, though it has pursued exits through trade sales — such as the 2021 sale of Fitprime.

Initial investment tickets range from €50,000 to €150,000 at the pre-seed and seed stages. LVenture reserves additional capital for follow-on funding across three to four subsequent rounds as companies reach product-market fit and generate revenue. The firm typically avoids leading Series A rounds but will participate pro-rata alongside larger Italian and European venture funds.

Yes — LVenture regularly syndicates rounds with Italian institutional co-investors including CDP Venture Capital and regional angel networks. Several portfolio companies have attracted follow-on capital from international funds based in London and Berlin, though the firm itself concentrates its direct origination within Italy and select Mediterranean markets.

LVenture has publicly stated that it does not invest in hardware-intensive deep technology, biotech requiring regulatory approval, or capital-intensive manufacturing — effectively ruling out cleantech hardware, medical devices, and semiconductor fabrication. The firm's stated focus is digital-first companies with software-centric business models and asset-light scaling paths.

LVenture operates the LUISS EnLabs accelerator in partnership with Rome's LUISS Guido Carli University, a private institution known for its business and law programs. The accelerator is housed on the university's campus near Rome's Termini station, giving LVenture early access to student-founded startups and academic research projects. The university is a strategic partner rather than a parent entity or controlling shareholder.